PAR 1.92% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-33

  1. 6,870 Posts.
    lightbulb Created with Sketch. 511
    had another look at the numbers...the cash balance at start of Q was $33.5m and finished at $26.2m, that was about $7.2 millions reduction.
    But the company has received R&D refund of $7.3m during the Quarter, so the actual cash reduction should be 7.2+7.3=$14.5 millions?
    not sure if I'm right about this, anyone?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.005(1.92%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $261.4K 990.7K

Buyers (Bids)

No. Vol. Price($)
1 9999 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 9445 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.